Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

What You Need to Know Ahead of Danaher’s Earnings Release

Washington, D.C.-based Danaher Corporation (DHR) is a global life sciences and diagnostics company that develops the tools, technologies and services used to advance biomedical research, manufacture medicines and diagnose diseases. The company has a market cap of $135.3 billion and operates through Biotechnology, Life Sciences, and Diagnostics segments.

DHR is expected to release its Q3 2026 earnings on Wednesday, Oct. 21, before the market opens. Ahead of the event, analysts expect the company’s EPS to be $1.96 on a diluted basis, up 3.7% from $1.89 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.